Mealey's (June 23, 2022, 12:04 PM EDT) -- WASHINGTON, D.C. — The Food and Drug Administration on June 23 ordered e-cigarette maker JUUL Labs Inc. (JLI) to stop selling or distributing all of its products in the United States, writing that it denied JLI’s premarket tobacco applications (PMTAs) because JLI did not provide “sufficient evidence . . . to demonstrate that marketing of the products would be appropriate for the protection of the public health.”...